268 related articles for article (PubMed ID: 25285458)
1. A preclinical murine model of hepatic metastases.
Soares KC; Foley K; Olino K; Leubner A; Mayo SC; Jain A; Jaffee E; Schulick RD; Yoshimura K; Edil B; Zheng L
J Vis Exp; 2014 Sep; (91):51677. PubMed ID: 25285458
[TBL] [Abstract][Full Text] [Related]
2. Description of a murine model of experimental hepatic metastases.
Goldrosen MH; Paolini N; Holyoke ED
J Natl Cancer Inst; 1986 Sep; 77(3):823-8. PubMed ID: 3462419
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of liver-specific metastatic tumor spread in a murine tumor model.
Edel G
J Cancer Res Clin Oncol; 1988; 114(1):47-58. PubMed ID: 3350842
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma.
Nikfarjam M; Yeo D; He H; Baldwin G; Fifis T; Costa P; Tan B; Yang E; Wen Sw; Christophi C
J Invest Surg; 2013 Dec; 26(6):352-9. PubMed ID: 23957638
[TBL] [Abstract][Full Text] [Related]
5. Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells.
Enomoto T; Oda T; Aoyagi Y; Sugiura S; Nakajima M; Satake M; Noguchi M; Ohkohchi N
Cancer Res; 2006 Dec; 66(23):11131-9. PubMed ID: 17145856
[TBL] [Abstract][Full Text] [Related]
6. [(111)In-DTPA]octreotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapy.
Pool SE; Kam BL; Koning GA; Konijnenberg M; Ten Hagen TL; Breeman WA; Krenning EP; de Jong M; van Eijck CH
Cancer Biother Radiopharm; 2014 May; 29(4):179-87. PubMed ID: 24820805
[TBL] [Abstract][Full Text] [Related]
7. A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice.
Furukawa T; Kubota T; Watanabe M; Kitajima M; Hoffman RM
Cancer Res; 1993 Jul; 53(13):3070-2. PubMed ID: 8319214
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model.
Partecke IL; Kaeding A; Sendler M; Albers N; Kühn JP; Speerforck S; Roese S; Seubert F; Diedrich S; Kuehn S; Weiss UF; Mayerle J; Lerch MM; Hadlich S; Hosten N; Heidecke CD; Puls R; von Bernstorff W
BMC Cancer; 2011 Jan; 11():40. PubMed ID: 21276229
[TBL] [Abstract][Full Text] [Related]
9. Murine portal vein catheterization to analyze liver-directed therapies.
Valentino JD; Rychahou PG; Mustain WC; Elliott VA; Evers BM
J Surg Res; 2013 Dec; 185(2):690-6. PubMed ID: 23890402
[TBL] [Abstract][Full Text] [Related]
10. A novel approach to the generation and identification of experimental hepatic metastases in a murine model.
Lafreniere R; Rosenberg SA
J Natl Cancer Inst; 1986 Feb; 76(2):309-22. PubMed ID: 3484792
[TBL] [Abstract][Full Text] [Related]
11. The influence of the microenvironment of liver-specific tumor cell colonization in a murine tumor model.
Edel G
J Cancer Res Clin Oncol; 1988; 114(2):163-9. PubMed ID: 3350849
[TBL] [Abstract][Full Text] [Related]
12. Novel mouse models of hepatic artery infusion.
Kim M; Fisher DT; Powers CA; Gabriel EM; Korman AM; Sexton S; Gudkov AV; Skitzki JJ
J Surg Res; 2017 Nov; 219():25-32. PubMed ID: 29078890
[TBL] [Abstract][Full Text] [Related]
13. Effect of E7010 on liver metastasis and life span of syngeneic C57BL/6 mice bearing orthotopically transplanted murine Colon 38 tumor.
Funahashi Y; Koyanagi N; Kitoh K
Cancer Chemother Pharmacol; 2001; 47(2):179-84. PubMed ID: 11269745
[TBL] [Abstract][Full Text] [Related]
14. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma.
Wang B; Xiong Q; Shi Q; Le X; Abbruzzese JL; Xie K
Cancer Res; 2001 Jan; 61(1):71-5. PubMed ID: 11196200
[TBL] [Abstract][Full Text] [Related]
15. Enhanced colorectal cancer metastases in the alcohol-injured liver.
Mohr AM; Gould JJ; Kubik JL; Talmon GA; Casey CA; Thomas P; Tuma DJ; McVicker BL
Clin Exp Metastasis; 2017 Feb; 34(2):171-184. PubMed ID: 28168393
[TBL] [Abstract][Full Text] [Related]
16. Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells.
Stangl S; Wortmann A; Guertler U; Multhoff G
J Immunol; 2006 May; 176(10):6270-6. PubMed ID: 16670338
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models.
Graham KC; Wirtzfeld LA; MacKenzie LT; Postenka CO; Groom AC; MacDonald IC; Fenster A; Lacefield JC; Chambers AF
Cancer Res; 2005 Jun; 65(12):5231-7. PubMed ID: 15958568
[TBL] [Abstract][Full Text] [Related]
18. Arabinogalactan blockade of experimental metastases to liver by murine hepatoma.
Hagmar B; Ryd W; Skomedal H
Invasion Metastasis; 1991; 11(6):348-55. PubMed ID: 1822847
[TBL] [Abstract][Full Text] [Related]
19. A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines.
Partecke LI; Sendler M; Kaeding A; Weiss FU; Mayerle J; Dummer A; Nguyen TD; Albers N; Speerforck S; Lerch MM; Heidecke CD; von Bernstorff W; Stier A
Eur Surg Res; 2011; 47(2):98-107. PubMed ID: 21720167
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of the organ preference of liver selected 'high metastatic' Lewis lung tumor cell line.
Paku S; Rot A; Ladányi A; Lapis K
Clin Exp Metastasis; 1989; 7(6):599-607. PubMed ID: 2776366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
